Stem cell therapy for chronic stroke patients
Part of Brain & nervous system, Heart & circulation, Immune system & allergy, Lungs & breathing clinical trials.
This trial tests whether a patient's own stem cells can be safely injected into the brain to help recovery after a stroke. It is for people who had an ischemic stroke 6 months to 5 years ago and still have moderate to severe symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 70 years old
- You had an ischemic stroke (clot-caused) between 6 months and 5 years ago
- You have moderate to severe weakness or disability from the stroke
- You have not had a major disability before the stroke
- You are able to have an MRI scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests a stem cell treatment for certain types of stroke, focusing first on safety and the right dose. It may help doctors learn whether the treatment is safe and potentially beneficial when given soon after stroke begins.
This study tests whether bone-marrow stem cells can improve nerve function in people with nerve damage that usually doesn’t recover with current care. It also checks whether the treatment is safe and whether people can be followed over time with repeated nerve exams.
This trial tests whether a patient's own bone marrow stem cells, given through a vein, can help improve recovery after a stroke. It is for people who had a moderate stroke 3 to 12 months ago and still have some disability.
This trial is testing a new treatment using stem cells from donated umbilical cord tissue to help people recover from a recent moderate to severe stroke. It is for patients who cannot receive standard clot-busting treatments.
This trial tests whether a special type of stem cell (from umbilical cord) can help people recover after a recent ischemic stroke. It aims to see if this treatment can improve movement and reduce disability.
This trial tests whether a single infusion of umbilical cord stem cells can help people recover from a recent ischemic stroke (stroke caused by a clot). It is for patients who have had their stroke within the last 72 hours and have moderate to severe symptoms.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.